Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MicroStrategy is a global leader in enterprise analytics and mobility software, providing a comprehensive platform for business intelligence and data visualization. The company's flagship product, MicroStrategy ONE, enables organizations to deploy AI-powered insights and hyper-intelligence applications across various industries, including healthcare and life sciences. In addition to its software operations, MicroStrategy has gained significant prominence for its corporate strategy of acquiring and holding Bitcoin as a primary treasury reserve asset. The company positions itself as a Bitcoin development company, leveraging its software expertise to support the Bitcoin network. While it serves pharmaceutical and healthcare clients with data solutions, it does not engage in drug discovery or clinical development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MicroStrategy.